Hydrogen water alleviates obliterative airway disease in mice
ConclusionsHydrogen water suppressed the development of mid-term obliterative airway disease in a mouse tracheal allograft model via anti-oxidant and -inflammatory mechanisms and through the activation of Tregs. Thus, hydrogen water is a potential treatment strategy for BOS that can improve the outcome of lung transplant patients.
Source: General Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
More News: Antidoxidants | Bone Graft | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Heart | Lung Transplant | Study | Transplant Surgery | Transplants